
March 10 (Reuters) - 2Seventy Bio Inc TSVT.O:
2SEVENTY BIO ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY BRISTOL MYERS SQUIBB
2SEVENTY BIO INC - DEAL VALUED AT $5.00 PER SHARE, ALL-CASH TRANSACTION
2SEVENTY BIO INC - TOTAL EQUITY VALUE OF APPROXIMATELY $286 MILLION
2SEVENTY BIO INC - DEAL REPRESENTS 88% PREMIUM TO CLOSING PRICE